{"id":"W2162966458","doi":"10.1111/j.1365-2125.2009.03450.x","title":"Tolerability and safety of GS‐101 eye drops, an antisense oligonucleotide to insulin receptor substrate‐1: a ‘first in man’ Phase I investigation","year":2009,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Tolerability; Angiogenesis; Pharmacology; Medicine; Cornea; Corneal neovascularization; In vivo; Neovascularization; Cancer research; Ophthalmology; Biology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001946596,0.001582028,0.0022807,0.0003496347,0.0003554344,0.00118788,0.0007289731,0.001451389,0.004937343],"category_scores_gemma":[0.001077042,0.0004569904,0.001970083,0.0002721458,0.0008834797,0.001167301,0.0002332088,0.00278641,0.001034517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006372362,"about_ca_system_score_gemma":0.001087147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004447594,"about_ca_topic_score_gemma":0.0006887265,"domain_scores_codex":[0.9992837,0.0003730471,0.0000326047,0.00009359813,0.00009159427,0.000125459],"domain_scores_gemma":[0.998895,0.0002539924,0.0002713939,0.0001353139,0.0001377148,0.0003066039],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2795134,0.1611591,0.00350712,0.003262528,0.002270302,0.0008504477,0.000788009,0.002578342,0.3256832,0.0007529209,0.01184543,0.2077891],"study_design_scores_gemma":[0.03328901,0.9390733,0.004461501,0.00007037774,0.0004372298,0.0003574274,0.00008060664,0.0005916365,0.01512145,0.0002007519,0.006273631,0.00004309472],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9761875,0.007373084,0.004790182,0.001102349,0.0004992312,0.00491802,0.001911941,0.0003085257,0.002909185],"genre_scores_gemma":[0.9715713,0.006948259,0.00476711,0.002299704,0.000560757,0.003428682,0.002893245,0.0001596346,0.007371262],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004937343,"threshold_uncertainty_score":0.0165171,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04532427982071825,"score_gpt":0.4247389389856438,"score_spread":0.3794146591649256,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}